The Column
The biopharmaceutical industry continues to focus on the development of biotherapeutic monoclonal antibody (mAbs) drugs. In this article, the compatibility of SEC coupled with HRAM–MS for the analysis of mAbs is demonstrated.
Zhiqi Hao
Advertisement
Articles by Zhiqi Hao
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
LCGC Announces the 2027 Winners of the Lifetime Achievement and Emerging Leader in Chromatography Awards
2
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
3
LC-MS/MS Tracks Herbal Stroke Remedy in the Brain
4
HPLC Tracks Bupivacaine Nanoparticles for Pain
5